Invention Grant
- Patent Title: Methods of treating autoimmune and/or glomerulonephritis-associated diseases using SHP2 inhibitors
-
Application No.: US15813729Application Date: 2017-11-15
-
Publication No.: US10092543B2Publication Date: 2018-10-09
- Inventor: Zhong-Yin Zhang , Maria Kontaridis , Li-Fan Zeng , Jianxun Wang
- Applicant: Indiana University Research and Technology Corporation , Beth Israel Deaconess Medical Center, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Indiana University Research and Technology Corporation
- Current Assignee: Indiana University Research and Technology Corporation
- Current Assignee Address: US IN Indianapolis
- Agency: Stinson Leonard Street LLP
- Main IPC: A61K31/404
- IPC: A61K31/404 ; A61K31/427 ; A61K31/4178 ; A61K31/433 ; A61K31/428 ; A61K31/4184 ; A61K31/4025
Abstract:
Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).
Public/Granted literature
- US20180071252A1 METHODS OF TREATING AUTOIMMUNE AND/OR GLOMERULONEPHRITIS-ASSOCIATED DISEASES USING SHP2 INHIBITORS Public/Granted day:2018-03-15
Information query
IPC分类:
